253 related articles for article (PubMed ID: 30355016)
1. Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II
Hermans MP; Gevaert S; Descamps O; Missault L; Gillot B; De Keyzer D; Lautsch D; Brudi P; Ambegaonkar B; Vyas A; Horack M; Gitt A
Acta Clin Belg; 2019 Dec; 74(6):399-404. PubMed ID: 30355016
[No Abstract] [Full Text] [Related]
2. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
[TBL] [Abstract][Full Text] [Related]
3. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
Ferrieres J; De Ferrari GM; Hermans MP; Elisaf M; Toth PP; Horack M; Brudi P; Lautsch D; Bash LD; Baxter CA; Ashton V; Ambegaonkar B; Gitt AK
Eur J Prev Cardiol; 2018 Dec; 25(18):1966-1976. PubMed ID: 30335504
[TBL] [Abstract][Full Text] [Related]
4. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy.
De Ferrari GM; Perna GP; Nicosia A; Guasti L; Casu G; Cuccia C; Picco F; Strazzella C; Totaro R; Cercone S; Canullo L; Horack M; Lautsch D; Gitt AK; Di Biase M
J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):485-490. PubMed ID: 29917002
[TBL] [Abstract][Full Text] [Related]
5. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
7. Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China.
Guo T; Chu C; Wang Y; He M; Jia H; Sun Y; Wang D; Liu Y; Huo Y; Mu J
BMC Cardiovasc Disord; 2023 Jul; 23(1):337. PubMed ID: 37393236
[TBL] [Abstract][Full Text] [Related]
8. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
[TBL] [Abstract][Full Text] [Related]
9. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
Wang X; He Y; Wang T; Li C; Ma Z; Zhang H; Ma H; Zhao H
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
[TBL] [Abstract][Full Text] [Related]
11. Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II.
Buddhari W; Uerojanaungkul P; Sriratanasathavorn C; Sukonthasarn A; Ambegaonkar B; Brudi P; Horack M; Lautsch D; Vyas A; Gitt AK
Heart Lung Circ; 2020 Mar; 29(3):405-413. PubMed ID: 31006593
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.
Yan BP; Chiang FT; Ambegaonkar B; Brudi P; Horack M; Lautsch D; Vyas A; Gitt AK
Int J Cardiol; 2018 Aug; 265():1-5. PubMed ID: 29885676
[TBL] [Abstract][Full Text] [Related]
13. Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.
Gong Y; Li X; Ma X; Yu H; Li Y; Chen J; Zhang G; Wang B; Qi X; Meng H; Wang X; Mu J; Hu X; Wang J; Liu S; Liu G; Yang Z; Zhou Y; Kong X; Yan Y; Wang C; Wang JA; Wang L; Fu G; Wei L; Peng D; Zhang S; Li R; Mao A; Bian R; Tang W; Ran Y; Jiang J; Huo Y
Clin Cardiol; 2021 Nov; 44(11):1575-1585. PubMed ID: 34651329
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II.
Poh KK; Chin CT; Tong KL; Tan JKB; Lim JS; Yu W; Horack M; Vyas A; Lautsch D; Ambegaonkar B; Brudi P; Gitt AK
Singapore Med J; 2019 Sep; 60(9):454-462. PubMed ID: 30773600
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS).
Devroey D; Radermecker RP; Van der Schueren BJ; Torbeyns B; Jaken RJ
Int J Clin Pract; 2014 Feb; 68(2):180-7. PubMed ID: 24308644
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
Gitt AK; Lautsch D; Ferrieres J; Kastelein J; Drexel H; Horack M; Brudi P; Vanneste B; Bramlage P; Chazelle F; Sazonov V; Ambegaonkar B
Atherosclerosis; 2016 Dec; 255():200-209. PubMed ID: 27667299
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II.
Poh KK; Ambegaonkar B; Baxter CA; Brudi P; Buddhari W; Chiang FT; Horack M; Jang Y; Johnson B; Lautsch D; Sawhney J; Vyas A; Yan BP; Gitt AK
Eur J Prev Cardiol; 2018 Dec; 25(18):1950-1963. PubMed ID: 30198749
[TBL] [Abstract][Full Text] [Related]
18. Do acute coronary events affect lipid management and cholesterol goal attainment in Germany? : Results from the Dyslipidemia International study II.
Gitt AK; Rieber J; Hambrecht R; Brachmann J; Graf K; Horack M; Karmann B; Vyas A; Lautsch D; Ambegaonkar B; Brudi P
Wien Klin Wochenschr; 2018 Dec; 130(23-24):707-715. PubMed ID: 30178071
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.
Jones PH; Nair R; Thakker KM
J Am Heart Assoc; 2012 Dec; 1(6):e001800. PubMed ID: 23316314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]